Head-to-head comparison of 5-azacitidine versus decitabine for the treatment of myelodysplastic syndrome

被引:0
|
作者
Kim, I. [1 ]
Lee, Y. G. [1 ]
Yoon, S. S. [1 ]
Park, S. [1 ]
Cheong, J. W. [2 ]
Min, Y. H. [2 ]
Bang, S. M. [3 ]
Kim, C. S. [4 ]
Park, Y. [5 ]
Mun, Y. C. [6 ]
Seong, C. M. [6 ]
Park, J. [7 ]
Lee, J. H. [7 ]
Lee, H. G. [8 ]
Kim, Y. K. [9 ]
Kim, H. J. [9 ]
机构
[1] Seoul Natl Univ, Coll Med, Hematol, Seoul, South Korea
[2] Yonsei Univ, Severance Hosp, Hematol, Seoul 120749, South Korea
[3] Bundang Seoul Natl Univ Hosp, Hematol, Songnam, South Korea
[4] Inha Univ, Coll Med, Hematol, Inchon, South Korea
[5] Korea Univ, Anam Hosp, Hematol, Seoul, South Korea
[6] Ewha Womans Univ, Mokdong Hosp, Hematol, Seoul, South Korea
[7] Gachon Univ, Gil Hosp, Hematol, Inchon, South Korea
[8] Konkuk Univ, Med Ctr, Hematol, Seoul, South Korea
[9] Chonnam Natl Univ, Hwasun Hosp, Hematol, Hwasun, South Korea
关键词
D O I
10.1016/S0145-2126(13)70041-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O-019
引用
收藏
页码:S17 / S17
页数:1
相关论文
共 50 条
  • [1] Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome
    Lee, Yun-Gyoo
    Kim, Inho
    Yoon, Sung-Soo
    Park, Seonyang
    Cheong, June-Won
    Min, Yoo-Hong
    Bang, Soo-Mee
    Kim, Chul Soo
    Park, Yong
    Mun, Yeung Chul
    Park, Jinny
    Lee, Jae Hoon
    Lee, Hong Ghi
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    BLOOD, 2012, 120 (21)
  • [2] OUTCOME OF 5-AZACITIDINE AND DECITABINE TREATMENT IN ELDERLY PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Nam, S.
    Lim, T.
    Kim, B.
    HAEMATOLOGICA, 2013, 98 : 588 - 588
  • [3] Outcome of 5-Azacitidine and Decitabine Treatment in Elderly Patients with Myelodysplastic Syndrome
    Nam, Seung-Hyun
    Lim, Taekyu
    Kim, Bong-Seog
    BLOOD, 2012, 120 (21)
  • [4] Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis
    Kumar, Ambuj
    List, Alan F.
    Hozo, Iztok
    Komrokji, Rami
    Djulbegovic, Benjamin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 340 - 342
  • [5] DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome
    Huong Thi Thanh Tran
    Kim, Hee Nam
    Lee, Il-Kwon
    Kim, Yeo-Kyeoung
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (02) : 207 - 213
  • [6] DNA Methylation Changes Following 5-Azacitidine Treatment in Patients with Myelodysplastic Syndrome
    Tran, Huong Thi Thanh
    Kim, Hee Nam
    Kim, Yeo-Kyeoung
    Ahn, Jae-Sook
    Lee, Il-Kwon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Hoon, Kook
    Hwang, Tai Ju
    Kim, Hyeoung-Joon
    BLOOD, 2009, 114 (22) : 1091 - 1092
  • [7] Late Hematological Improvement of Myelodysplastic Syndrome Following Treatment with 5-Azacitidine Therapy
    Takaoka, Kensuke
    Hangaishi, Akira
    Ito, Ayumu
    Morioka, Takehiko
    Kida, Michiko
    Usuki, Kensuke
    INTERNAL MEDICINE, 2014, 53 (19) : 2241 - 2243
  • [8] Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome
    Nishihori, Taiga
    Perkins, Janelle
    Mishra, Asmita
    Komrokji, Rami
    Kim, Jongphil
    Kharfan-Dabaja, Mohamed A.
    Perez, Lia
    Lancet, Jeffrey
    Fernandez, Hugo
    List, Alan
    Anasetti, Claudio
    Field, Teresa
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (06) : 776 - 780
  • [9] Head-to-head comparison of micafungin versus caspofungin in the treatment of invasive candidiasis
    Michael A. Pfaller
    Current Fungal Infection Reports, 2009, 3 (3) : 127 - 128
  • [10] Head-to-Head Comparison of Micafungin Versus Caspofungin in the Treatment of Invasive Candidiasis
    Pappas, P. G.
    Rotstein, C. M.
    Betts, R. F.
    CURRENT FUNGAL INFECTION REPORTS, 2009, 3 (03) : 127 - 128